Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis

Molecular Biology of the Cell

Volumn 22, Issue 3, 2011, Pages 327-341

  Deakin, Nicholas O ^a   Turner, Christopher E ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; PAXILLIN; PROTEIN HIC 5; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL POPULATION; CELL STRUCTURE; EXTRACELLULAR MATRIX; LUNG METASTASIS; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CATTLE; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PAXILLIN; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

EID: 79551657030     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E10-09-0790     Document Type: Article

References (99)

1. Avraamides C, Bromberg ME, Gaughan JP, Thomas SM, Tsygankov AY, Panetti TS (2007). Hic-5 promotes endothelial cell migration to lysophosphatidic acid. Am J Physiol Heart Circ Physiol 293, H193-H203. (Pubitemid 47105074)
2. Azuma K, Tanaka M, Uekita T, Inoue S, Yokota J, Ouchi Y, Sakai R (2005). Tyrosine phosphorylation of paxillin affects the metastatic potential of human osteosarcoma. Oncogene 24, 4754-4764. (Pubitemid 41076293)
3. Ballestrem C, Erez N, Kirchner J, Kam Z, Bershadsky A, Geiger B (2006). Molecular mapping of tyrosine-phosphorylated proteins in focal adhesions using fluorescence resonance energy transfer. J Cell Sci 119, 866-875.
4. Bass MD, Roach KA, Morgan MR, Mostafavi-Pour Z, Schoen T, Muramatsu T, Mayer U, Ballestrem C, Spatz JP, Humphries MJ (2007). Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix. J Cell Biol 177, 527-538. (Pubitemid 46718280)
5. Bellis SL, Miller JT, Turner CE (1995). Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J Biol Chem 270, 17437-17441.
6. Bertolucci CM, Guibao CD, Zheng J (2005). Structural features of the focal adhesion kinase-paxillin complex give insight into the dynamics of focal adhesion assembly. Protein Sci 14, 644-652.
7. Bertolucci CM, Guibao CD, Zheng JJ (2008). Phosphorylation of paxillin LD4 destabilizes helix formation and inhibits binding to focal adhesion kinase. Biochemistry 47, 548-554.
8. Bos PD et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009.
9. Bristow JM, Sellers MH, Majumdar D, Anderson B, Hu L, Webb DJ (2009). The Rho-family GEF Asef2 activates Rac to modulate adhesion and actin dynamics and thereby regulate cell migration. J Cell Sci 122, 4535-4546.
10. Broussard JA, Webb DJ, Kaverina I (2008). Asymmetric focal adhesion disassembly in motile cells. Curr Opin Cell Biol 20, 85-90.
11. Brown MC, Perrotta JA, Turner CE (1996). Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J Cell Biol 135, 1109-1123.
12. Brown MC, Turner CE (2004). Paxillin: adapting to change. Physiol Rev 84, 1315-1339.
13. Cailleau R, Olive M, Cruciger QV (1978). Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14, 911-915. (Pubitemid 9089089)
14. Carragher NO, Walker SM, Scott Carragher LA, Harris F, Sawyer TK, Brunton VG, Ozanne BW, Frame MC (2006). Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function. Oncogene 25, 5726-5740.
15. Castello-Cros R, Cukierman E (2009). Stromagenesis during tumorigenesis: characterization of tumor-associated fibroblasts and stroma-derived 3D matrices. Methods Mol Biol 522, 275-305.
16. Caswell PT et al. (2007). Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments. Dev Cell 13, 496-510.
17. Choi CK, Vicente-Manzanares M, Zareno J, Whitmore LA, Mogilner A, Horwitz AR (2008). Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner. Nat Cell Biol 10, 1039-1050.
18. Chrzanowska-Wodnicka M, Burridge K (1996). Rho-stimulated contractility drives the formation of stress fibers and focal adhesions. J Cell Biol 133, 1403-1415.
19. Coussens LM, Fingleton B, Matrisian LM (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392.
20. Cui W, Wang X, Liu YC, Wan YL, Guo HJ, Zhu J (2006). Expression of HIC-5/ARA55 in colonrectal cancer and its mechanisms of action. Beijing Da Xue Xue Bao 38, 280-283.
21. Cukierman E (2004). A visual-quantitative analysis of fibroblastic stromagenesis in breast cancer progression. J Mammary Gland Biol Neoplasia 9, 311-324.
22. Cukierman E, Pankov R, Stevens DR, Yamada KM (2001). Taking cell-matrix adhesions to the third dimension. Science 294, 1708-1712.
23. Deakin NO, Bass MD, Warwood S, Schoelermann J, Mostafavi-Pour Z, Knight D, Ballestrem C, Humphries MJ (2009). An integrin-alpha4-14-3-3zeta-paxillin ternary complex mediates localised Cdc42 activity and accelerates cell migration. J Cell Sci 122, 1654-1664.
24. Deakin NO, Turner CE (2008). Paxillin comes of age. J Cell Sci 121, 2435-2444.
25. Dumbauld DW, Shin H, Gallant ND, Michael KE, Radhakrishna H, Garcia AJ (2010). Contractility modulates cell adhesion strengthening through focal adhesion kinase and assembly of vinculin-containing focal adhesions. J Cell Physiol 223, 746-756.
26. Estecha A, Sanchez-Martin L, Puig-Kroger A, Bartolome RA, Teixido J, Samaniego R, Sanchez-Mateos P (2009). Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion. J Cell Sci 122, 3492-3501.
27. Even-Ram S, Doyle AD, Conti MA, Matsumoto K, Adelstein RS, Yamada KM (2007). Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk. Nat Cell Biol 9, 299-309.
28. Fackler OT, Grosse R (2008). Cell motility through plasma membrane blebbing. J Cell Biol 181, 879-884.
29. Farmer P et al. (2005). Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24, 4660-4671.
30. Friedl P, Noble PB, Walton PA, Laird DW, Chauvin PJ, Tabah RJ, Black M, Zanker KS (1995). Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res 55, 4557-4560.
31. Friedl P, Wolf K (2003). Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374.
32. Friedl P, Wolf K (2009). Plasticity of cell migration: a multiscale tuning model. J Cell Biol 188, 11-19.
33. Fujimoto N, Mizokami A, Harada S, Matsumoto T (2001). Different expression of androgen receptor coactivators in human prostate. Urology 58, 289-294. (Pubitemid 32728083)
34. Fujita H, Kamiguchi K, Cho D, Shibanuma M, Morimoto C, Tachibana K (1998). Interaction of Hic-5, A senescence-related protein, with focal adhesion kinase. J Biol Chem 273, 26516-26521. (Pubitemid 28471660)
35. Gadea G, Sanz-Moreno V, Self A, Godi A, Marshall CJ (2008). DOCK10- mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr Biol 18, 1456-1465.
36. Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E (2009). Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11, 1287-1296.
37. Giannone G et al. (2007). Lamellipodial actin mechanically links myosin activity with adhesion-site formation. Cell 128, 561-575.
38. Guignandon A, Boutahar N, Rattner A, Vico L, Lafage-Proust MH (2006). Cyclic strain promotes shuttling of PYK2/Hic-5 complex from focal contacts in osteoblast-like cells. Biochem Biophys Res Commun 343, 407-414.
39. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas SM (2002). The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 22, 901-915.
40. Heitzer MD, DeFranco DB (2006). Hic-5, an adaptor-like nuclear receptor coactivator. Nucl Recept Signal 4, e019.
41. Hennigan RF, Hawker KL, Ozanne BW (1994). Fos-transformation activates genes associated with invasion. Oncogene 9, 3591-3600.
42. Hetey SE, Lalonde DP, Turner CE (2005). Tyrosine-phosphorylated Hic-5 inhibits epidermal growth factor-induced lamellipodia formation. Exp Cell Res 311, 147-156.
43. Inui S., Shono F, Noguchi F, Nakajima T, Hosokawa K, Itami S (2010). In vitro and in vivo evidence of pathogenic roles of Hic-5/ARA55 in keloids through Smad pathway and profibrotic transcription. J Dermatol Sci 58, 2 152-154.
44. Iwasaki T et al. (2002). Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin in MM1 cancer cell migration. Int J Cancer 97, 330-335.
45. Jones ML, Shawe-Taylor AJ, Williams CM, Poole AW (2009). Characterization of a novel focal adhesion kinase inhibitor in human platelets. Biochem Biophys Res Commun 389, 198-203.
46. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549.
47. Kanteti R, Yala S, Ferguson MK, Salgia R (2009). MET, HGF, EGFR, and PXN gene copy number in lung cancer using DNA extracts from FFPE archival samples and prognostic significance. J Environ Pathol Toxicol Oncol 28, 89-98.
48. Kim-Kaneyama JR, Suzuki W, Ichikawa K, Ohki T, Kohno Y, Sata M, Nose K, Shibanuma M (2005). Uni-axial stretching regulates intracellular localization of Hic-5 expressed in smooth-muscle cells in vivo. J Cell Sci 118, 937-949.
49. Lammermann T et al. (2008). Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453, 51-55.
50. Machacek M, Hodgson L, Welch C, Elliott H, Pertz O, Nalbant P, Abell A, Johnson GL, Hahn KM, Danuser G (2009). Coordination of Rho GTPase activities during cell protrusion. Nature 461, 99-103.
51. Mestayer C, Blanchere M, Jaubert F, Dufour B, Mowszowicz I (2003). Expression of androgen receptor coactivators in normal and cancer prostate tissues and cultured cell lines. Prostate 56, 192-200.
52. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005). Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524. (Pubitemid 41112921)
53. Miyoshi Y, Ishiguro H, Uemura H, Fujinami K, Miyamoto H, Miyoshi Y, Kitamura H, Kubota Y (2003). Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer. Prostate 56, 280-286.
54. Nagata M et al. (2003). Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 106, 683-689.
55. Nishiya N, Shirai T, Suzuki W, Nose K (2002). Hic-5 interacts with GIT1 with a different binding mode from paxillin. J Biochem 132, 279-289.
56. Nishiya N, Tachibana K, Shibanuma M, Mashimo JI, Nose K (2001). Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase. Mol Cell Biol 21, 5332-5345.
57. Nobes CD, Hall A (1999). Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144, 1235-1244.
58. Overall CM, Lopez-Otin C (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2, 657-672.
59. Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, Matsumoto K, Yamada KM (2005). A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 170, 793-802.
60. Parri M, Taddei ML, Bianchini F, Calorini L, Chiarugi P (2009). EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style. Cancer Res 69, 2072-2081.
61. Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM (2000). Phosphorylation of tyrosine residues 31 and 118 on paxillin regulates cell migration through an association with CRK in NBT-II cells. J Cell Biol 148, 957-970.
62. Petrie RJ, Doyle AD, Yamada KM (2009). Random versus directionally persistent cell migration. Nat Rev Mol Cell Biol 10, 538-549.
63. Pinner S, Sahai E (2008). PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol 10, 127-137.
64. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ (2006). Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 4, 38.
65. Provenzano PP, Eliceiri KW, Keely PJ (2009). Multiphoton microscopy and fluorescence lifetime imaging microscopy (FLIM) to monitor metastasis and the tumor microenvironment. Clin Exp Metastasis 26, 357-370.
66. Radvanyi L et al. (2005). The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc Natl Acad Sci USA 102, 11005-11010.
67. Rathore VB, Okada M, Newman PJ, Newman DK (2007). Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. Biochem J 403, 275-281.
68. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S (2006). X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132.
69. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR (2003). Cell migration: integrating signals from front to back. Science 302, 1704-1709.
70. Riento K, Ridley AJ (2003). Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4, 446-456.
71. Rodina A, Schramm K, Musatkina E, Kreuser ED, Tavitian A, Tatosyan A (1999). Phosphorylation of p125FAK and paxillin focal adhesion proteins in src-transformed cells with different metastatic capacity. FEBS Lett 455, 145-148.
72. Rossier OM et al. (2010). Force generated by actomyosin contraction builds bridges between adhesive contacts. EMBO J 29, 1055-1068.
73. Sahai E, Garcia-Medina R, Pouyssegur J, Vial E (2007). Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J Cell Biol 176, 35-42.
74. Sahai E, Marshall CJ (2003). Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis. Nat Cell Biol 5, 711-719.
75. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, Pinner S, Sahai E, Marshall CJ (2008). Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510-523.
76. Shan Y, Yu L, Li Y, Pan Y, Zhang Q, Wang F, Chen J, Zhu X (2009). Nudel and FAK as antagonizing strength modulators of nascent adhesions through paxillin. PLoS Biol 7, e1000116.
77. Shi J, Wang S, Zhao E, Shi L, Xu X, Fang M (2010). Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma. J Oral Pathol Med 39, 7 548-551.
78. Slack-Davis JK et al. (2007). Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 282, 14845-14852.
79. Tachibana K, Sato T, D'Avirro N, Morimoto C (1995). Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J Exp Med 182, 1089-1099.
80. Thomas SM, Hagel M, Turner CE (1999). Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin. J Cell Sci 112, Pt 2 181-190.
81. Tumbarello DA, Brown MC, Hetey SE, Turner CE (2005). Regulation of paxillin family members during epithelial-mesenchymal transformation: a putative role for paxillin delta. J Cell Sci 118, 4849-4863.
82. Tumbarello DA, Turner CE (2007). Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway. J Cell Physiol 211, 736-747.
83. Turashvili G et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 7, 55.
84. Wang H, Song K, Sponseller TL, Danielpour D (2005). Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling. J Biol Chem 280, 7 5154-5162. (Pubitemid 40279985)
85. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6, 154-161. (Pubitemid 38425715)
86. West KA, Zhang H, Brown MC, Nikolopoulos SN, Riedy MC, Horwitz AF, Turner CE (2001). The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol 154, 161-176. (Pubitemid 34289286)
87. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P (2003). Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160, 267-277.
88. Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, Stack MS, Friedl P (2007). Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 9, 893-904.
89. Worthylake RA, Lemoine S, Watson JM, Burridge K (2001). RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol 154, 147-160.
90. Wyckoff JB, Pinner SE, Gschmeissner S, Condeelis JS, Sahai E (2006). ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol 16, 1515-1523.
91. Yang HJ, Chen JZ, Zhang WL, Ding YQ (2010). Focal adhesion plaque associated cytoskeletons are involved in the invasion and metastasis of human colorectal carcinoma. Cancer Invest 28, 127-134.
92. Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R (2001). A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res 16, 1486-1495.
93. Yoshida K, Soldati T (2006). Dissection of amoeboid movement into two mechanically distinct modes. J Cell Sci 119, 3833-3844.
94. Yu JA, Deakin NO, Turner CE (2009). Paxillin-kinase-linker tyrosine phosphorylation regulates directional cell migration. Mol Biol Cell 20, 4706-4719.
95. Zaidel-Bar R, Ballestrem C, Kam Z, Geiger B (2003). Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J Cell Sci 116, 4605-4613.
96. Zaidel-Bar R, Milo R, Kam Z, Geiger B (2007). A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J Cell Sci 120, 137-148.
97. Zhao H et al. (2004). Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15, 2523-2536.
98. Zouq NK, Keeble JA, Lindsay J, Valentijn AJ, Zhang L, Mills D, Turner CE, Streuli CH, Gilmore AP (2009). FAK engages multiple pathways to maintain survival of fibroblasts and epithelia: differential roles for paxillin and p130Cas. J Cell Sci 122, 357-367.
99. Zucker S, Cao J, Chen WT (2000). Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19, 6642-6650.